SANGAMO THERAPEUTICS INC (SGMO) Stock Institutional Trading Activity


SANGAMO THERAPEUTICS INC (SGMO) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC and First Eagle U.S. Value. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Renaissance Technologies LLCSell-1,752,1408,430,323$3,540,736
Q3 2025Renaissance Technologies LLCBuy3,343,02910,182,463$6,856,871
Q2 2025Renaissance Technologies LLCBuy3,671,3276,839,434$3,702,186
Q1 2025Renaissance Technologies LLCBuy83,2303,168,107$2,077,645
Q4 2024Renaissance Technologies LLCSell-1,767,9003,084,877$3,146,575
Q3 2024Renaissance Technologies LLCBuy726,2004,852,777$4,202,990
Q2 2024Renaissance Technologies LLCBuy1,528,6004,126,577$1,478,553
Q1 2024Renaissance Technologies LLCSell-547,9012,597,977$1,741
Q4 2023Renaissance Technologies LLCBuy780,1243,145,878$1,709
Q3 2023Renaissance Technologies LLCSell-701,7422,365,754$1,419
Q2 2023Renaissance Technologies LLCSell-165,2993,067,496$3,988
Q1 2023Renaissance Technologies LLCBuy1,113,2993,232,795$5,690
Q4 2022Renaissance Technologies LLCBuy453,4002,119,496$6,655
Q3 2022Renaissance Technologies LLCBuy226,6001,666,096$8,164
Q2 2022Renaissance Technologies LLCBuy676,4001,439,496$5,960
Q1 2022Renaissance Technologies LLCSell-87,600763,096$4,434
Q4 2021Renaissance Technologies LLCBuy115,196850,696$6,380
Q3 2021Renaissance Technologies LLCBuy152,300735,500$6,627
Q2 2021Renaissance Technologies LLCSell-196,600583,200$6,981
Q1 2021Renaissance Technologies LLCSell-512,800779,800$9,771
Q4 2020Renaissance Technologies LLCSell-32,8911,292,600$20,171
Q3 2020Renaissance Technologies LLCBuy1,258,4911,325,491$12,526
Q3 2019Renaissance Technologies LLCSell-559,80067,000$606
Q2 2019Renaissance Technologies LLCSell-278,400626,800$6,751
Q1 2019Renaissance Technologies LLCBuy881,400905,200$8,636
Q4 2017Renaissance Technologies LLCSell-298,01923,800$390
Q4 2016Renaissance Technologies LLCSell-272,681321,819$982
Q3 2016Renaissance Technologies LLCBuy480,300594,500$2,753
Q2 2016First Eagle U.S. ValueSell-319,72760,000$347
Q2 2016Renaissance Technologies LLCSell-389,864114,200$661

Frequently asked questions about SGMO activity

  • Which institutional owners are buying SGMO?

    Institutional owners buying SGMO include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in SGMO activity?

    "Buy" means an investor increased their reported position in SGMO compared to the prior reporting period. This reflects growing exposure to SANGAMO THERAPEUTICS INC (SGMO) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in SGMO increasing?

    Institutional interest in SGMO can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.